Aligos Therapeutics (ALGS)

• Market cap: $69.4M
• 1 day: -4.95%
• 5 days: 5.83%
• 1 month: 8.35%
• 3 months: 10.51%
• 6 months: 113.46%
• Year to date: -74.91%
• 1 year: 38.56%
• 5 years: -97.29%
• 10 years: -97.31%
• Sector: Healthcare
• Industry: Biotechnology

About: Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Employees: 70